Evidence map›Paper›PMID 40857061›Full record

ReviewJournal of cellular and molecular medicine2025

Hedgehog Signalling in Osteogenesis and Bone Metabolism: Molecular Mechanisms, Regulatory Networks and Implications for Skeletal Disease.

Rohey Njie, Shihan Xu, Taofen Wu, Jiashun Pi, Sisi Lin, Pengxiang Zhang, Jiaqi Wang, Qi Dai, Hui Shen, Nenghua Zhang and 1 more

Abstract readReview
In one paragraph

Review in Journal of cellular and molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rohey NjieDepartment of Biopharmaceutics, Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Science and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Shihan XuSchool of Life Sciences, University of Liverpool, Liverpool, UK.
Taofen WuR&D Department, Ceva Animal Health Technology (Hangzhou) Co. Ltd., Hangzhou, China.
Jiashun PiDepartment of Biopharmaceutics, Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Science and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Sisi LinDepartment of Biopharmaceutics, Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Science and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Pengxiang ZhangDepartment of Biopharmaceutics, Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Science and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Jiaqi WangDepartment of Biopharmaceutics, Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Science and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Qi DaiDepartment of Biopharmaceutics, Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Science and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Hui ShenClinical Laboratory, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing, China.
Nenghua ZhangClinical Laboratory, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing, China.
Guiqian ChenDepartment of Biopharmaceutics, Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Science and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.ORCID 0000-0001-6452-440X

Funding

Fundamental Research Funds of Zhejiang Sci-Tech University 2021Q031National Natural Science Foundation of China 81400489Special Support Plan for High-level Talents in Zhejiang Province 2021R52019Zhejiang Drug & Health Foundation 2022507032Zhejiang Drug & Health Foundation 2023KY340Zhejiang Jiaxing Science Technology Foundation 2020AY10001Zhejiang Jiaxing Science Technology Foundation 2023AY11045Zhejiang Jiaxing Science Technology Foundation 2023AY31012Zhejiang Jiaxing Science Technology Foundation 2023AZ31004Zhejiang Provincial Natural Science Foundation of China LGC22H20001Zhejiang Provincial Natural Science Foundation of China LTGY23H200006Zhejiang Provincial Natural Science Foundation of China LZ23H140001Zhejiang Qianjiang Talent Program 21040040-E
6 · The paper itself

Abstract

The Hedgehog (Hh) signalling pathway serves as a fundamental regulator in bone development and homeostasis, translating extracellular signals into precise transcriptional programmes that govern osteogenic differentiation and bone remodelling. Central to this process, ligand-dependent Hh activation induces the nuclear translocation of GLI transcription factors (GLI1/2/3), which orchestrate the expression of key osteogenic regulators, including RUNX2 and Osterix (OSX), thereby directing mesenchymal stem cell (MSC) fate commitment. Among Hh ligands, the Indian hedgehog (Ihh) plays a dominant role in endochondral ossification, spatiotemporally controlling osteoprogenitor differentiation and chondrocyte maturation. Notably, the Hh pathway engages in extensive, context-dependent crosstalk with Wnt/β-catenin, BMP, TGF-β, FGF and PTHrP signalling cascades, forming a highly interconnected regulatory network essential for skeletal patterning and morphogenesis. Dysregulation of this balanced system contributes to a spectrum of skeletal disorders, ranging from congenital defects to degenerative bone diseases, highlighting its critical role in maintaining bone integrity. This review synthesises recent advances in Hh-mediated osteogenesis, dissecting its multi-layered interactions within the skeletal gene regulatory framework. By unravelling the molecular logic of Hh-dependent signalling networks, we deepen our understanding of bone biology and illuminate novel therapeutic targets for skeletal pathologies through precision modulation of Hh pathway activity.

Indexed as

Bone and BonesBone DiseasesGene Regulatory NetworksHedgehog ProteinsOsteogenesisSignal TransductionAnimalsCell DifferentiationHumansHedgehog ProteinsBMP signallingbone formationHh signallingosteoblastsTGF signallingWnt signalling

Identifiers

PMID40857061
PMCPMC12379553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.